Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Non-alcoholic Steatohepatitis (DEAN)
NCT03723252Phase 3Completed
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Mar 2019
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dapagliflozin in Nonalcoholic steatohepatitis (NASH), sponsored by Nanfang Hospital, Southern Medical University. Started Mar 2019; status: completed.
02
Drugs
dapagliflozin
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT03723252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03723252.